Endovascular Transcatheter Aortic Valve Replacement Outcomes in Hypertrophic Cardiomyopathy: Insights from the National Inpatient Sample (2014–2018)
- 13 May 2023
- journal article
- research article
- Published by S. Karger AG in Cardiology
- Vol. 148 (3) , 289-292
Abstract
Background: Outcomes of patients with hypertrophic cardiomyopathy (HCM) following transcatheter aortic valve replacement (TAVR) remain largely unknown. Objectives: This study sought to assess the clinical characteristics and outcomes of HCM patients following TAVR. Methods: We queried the National Inpatient Sample from 2014 to 2018 for TAVR hospitalizations with and without HCM, creating a propensity-matched cohort to compare outcomes. Results: 207,880 patients that underwent TAVR during the study period, 810 (0.38%) had coexisting HCM. In the unmatched population, TAVR patients with HCM compared to those without HCM, were more likely to be female, had a higher prevalence of heart failure, obesity, cancer, and history of pacemaker/implantable cardioverter defibrillation, and were more likely to have nonelective and weekend admissions (p for all <0.05). TAVR patients without HCM had higher prevalence of coronary artery disease, prior percutaneous coronary intervention, prior coronary artery bypass grafting, and peripheral arterial disease compared to their counterparts (p for all <0.05). In the propensity-matched cohort, TAVR patients with HCM had significantly higher incidence of in-hospital mortality, acute kidney injury/hemodialysis, bleeding complications, vascular complications, permanent pacemaker requirement, aortic dissection, cardiogenic shock, and mechanical ventilation requirement. Conclusion: Endovascular TAVR in HCM patients is associated with an increased incidence of in-hospital mortality and procedural complications.Keywords
This publication has 9 references indexed in Scilit:
- Home Health Care Utilization Trend, Predictors, and Association With Early Rehospitalization Following Endovascular Transcatheter Aortic Valve ReplacementCardiovascular Revascularization Medicine, 2022
- Outcomes in Patients With Obstructive Hypertrophic Cardiomyopathy and Concomitant Aortic Stenosis Undergoing Surgical Myectomy and Aortic Valve ReplacementJournal of the American Heart Association, 2021
- Association of Hypertrophic Obstructive Cardiomyopathy With Outcomes Following Transcatheter Aortic Valve ReplacementJAMA Network Open, 2020
- Undiagnosed hypertrophic obstructive cardiomyopathy during transcatheter aortic valve replacement: a case reportJournal of Medical Case Reports, 2018
- Recurrence of Left Ventricular Outflow Tract Obstruction Requiring Alcohol Septal Ablation after Transcatheter Aortic Valve ImplantationCase Reports in Cardiology, 2018
- Evaluation and Management of Concomitant Hypertrophic Obstructive Cardiomyopathy and Valvular Aortic StenosisCurrent Treatment Options in Cardiovascular Medicine, 2016
- Combined Transcatheter Aortic Valve Replacement and Emergent Alcohol Septal AblationCirculation, 2013
- Alcohol septal ablation after transaortic valve implantation: The dynamic nature of left outflow tract obstructionCatheterization and Cardiovascular Interventions, 2012
- Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk PatientsNew England Journal of Medicine, 2011